July 16, 2018 Mr. Pritesh Shah Novocure USA LLC New York, NY 10036 Dear Pritesh:Release Agreement • October 25th, 2018 • NovoCure LTD • Surgical & medical instruments & apparatus • New York
The purposes of this letter (this "Agreement") are to amend and restate the terms and conditions of your Prior Agreement (as defined below) and to set forth and acknowledge certain terms of your continued employment with the Novocure Group. Your formal employment relationship will transfer to Novocure USA LLC, a Delaware limited liability corporation (the "Company") and a wholly owned subsidiary of NovoCure Limited, a Jersey (Channel Islands) corporation (the "Parent"). References herein to the "Novocure Group" shall mean and refer to, collectively, the Parent, the Company and their respective direct and indirect subsidiaries and affiliates. Upon the date this Agreement is executed (the "Effective Date"), this Agreement will supersede and replace in its entirety the employment letter agreement between you and the Company, dated as of September 29, 2017 (the' Prior Agreement").
LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • October 25th, 2018 • NovoCure LTD • Surgical & medical instruments & apparatus • New York
This License and Collaboration Agreement (this “Agreement”) is made as of September 10th, 2018 (the “Effective Date”), by and between NovoCure Limited, a corporation organized and existing under the laws of Jersey (“NVCR”), having a registered address at Second Floor, No. 4 The Forum, Grenville Street, St. Helier, Jersey JE2 4UF, and Zai Lab (Shanghai) Co., Ltd., a limited company organized under the laws of P.R. of China (“Zai”), having a place of business at 4560 Jinke Rd, Bldg. 1, 4/F, Pudong, Shanghai, China, 201210. NVCR and Zai are referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
